IBEX Ltd
For the period ended Jun 30, 2026. Filed Sep 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Sep 10, 2026
IBEX$52.23+3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(in thousands)
| Common Shares · Treasury Shares · AdditionalPaid-inCapital · Accumulated OtherComprehensiveLoss · Retained Earnings / (Deficit) · TotalStockholders'Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Amount | |||||||
| Balance, June 30, 2023 | 18,280 | $2 | $(3,682) | $204,734 | $(6,312) | $(44,778) | $149,964 |
| Net income for the period ended June 30, 2024 | — | — | — | — | — | 33,655 | 33,655 |
| Foreign currency translation adjustment | — | — | — | — | (1,623) | — | (1,623) |
| Changes in fair value of cash flow hedges | — | — | — | — | (111) | — | (111) |
| Purchase of treasury shares | (1,322) | — | (21,685) | — | — | — | (21,685) |
| Changes in defined benefit plan | — | — | — | — | 133 | — | 133 |
| Provision for common stock warrants | — | — | — | 1,183 | — | — | 1,183 |
| Issuance of common shares | 59 | — | — | 366 | — | — | 366 |
| Stock-based compensation expense | — | — | — | 3,917 | — | — | 3,917 |
| Balance, June 30, 2024 | 17,017 | $2 | $(25,367) | $210,200 | $(7,913) | $(11,123) | $165,799 |
| Net income for the period ended June 30, 2025 | — | — | — | — | — | 36,864 | 36,864 |
| Foreign currency translation adjustment | — | — | — | — | 1,114 | — | 1,114 |
| Changes in fair value of cash flow hedges | — | — | — | — | 775 | — | 775 |
| Purchase of treasury shares | (3,948) | (1) | (77,971) | — | — | — | (77,972) |
| Changes in defined benefit plan | — | — | — | — | (312) | — | (312) |
| Issuance of common shares | 289 | — | — | 4,307 | — | — | 4,307 |
| Stock-based compensation expense | — | — | — | 3,734 | — | — | 3,734 |
| Balance, June 30, 2025 | 13,358 | $1 | $(103,338) | $218,241 | $(6,336) | $25,741 | $134,309 |
| Net income for the period ended June 30, 2026 | — | — | — | — | — | 46,331 | 46,331 |
| Foreign currency translation adjustment | — | — | — | — | (3,140) | — | (3,140) |
| Changes in fair value of cash flow hedges | — | — | — | — | (2,535) | — | (2,535) |
| Purchase of treasury shares | (453) | — | (14,365) | — | — | — | (14,365) |
| Changes in defined benefit plan | — | — | — | — | 524 | — | 524 |
| Issuance of common shares | 473 | 1 | — | 4,077 | — | — | 4,078 |
| Shares withheld related to net share settlement of equity awards | (68) | — | — | (2,407) | — | — | (2,407) |
| Stock-based compensation expense | — | — | — | 7,435 | — | — | 7,435 |
| Balance, June 30, 2026 | 13,310 | $2 | $(117,703) | $227,346 | $(11,487) | $72,072 | $170,230 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.